Tri-Cities Tech Business Update
IsoRay names new acting CEO
IsoRay, a Richland, Wash. company specializing in production of Cesium-131 brachytherapy seeds for cancer treatment, announced that Chief Executive Officer Roger Girard resigned from the company for personal reasons and board member Dwight Babcock was named Chairman and Acting CEO. Babcock, with more than 30 years experience as a CEO, has realigned the management team to achieve the company's objectives of accelerating sales growth while reducing manufacturing costs and other expenses. The company continues to pursue new international opportunities, including its recent joint venture in Russia. During Girard's years of service, IsoRay achieved commercial-scale production of medical isotopes for cancer treatment.
Contact IsoRay at (509) 375-1202.
